1 – 4 of 4
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo
2010) In Proceedings of the National Academy of Sciences of the United States of America 107(28). p.51-12646(
- Contribution to journal › Article
-
Mark
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan
(
- Contribution to journal › Article
- 2007
-
Mark
Method for lipidomic analysis : p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells
(
- Contribution to journal › Article
- 1997
-
Mark
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset
(
- Contribution to journal › Article